Clinical Trial Update: Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study [Phase 4]

View source ↗

Summary

A Phase 4 real-world cohort study from Fujian Medical University examining genotype-driven neoadjuvant therapy for locally advanced thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Snippet

Sponsor: Fujian Medical University | Conditions: Thyroid Neoplasms | Phase 4 | Status: NOT_YET_RECRUITING